ArticleJournal of the National Cancer Institute2015

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Jun Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.